Last filing: Sep 2, 2026.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 0 of the 13 calendar months from Oct 2025 to Oct 2026.
- No sale on record before this period.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Martin Marietta Materials (MLM) | Director | Jul 16, 2019 | Sep 2, 2026 |
| Labcorp (LH) | Former Pres & CEO Clinical Business | Jan 11, 2023 | Jan 11, 2023 |
| IQVIA (IQV) | Former Vice Chair, Pres R&D Solutions, Director | May 8, 2013 | Oct 4, 2016 |
| Accenture (ACN) | Former Chief Risk Officer | Sep 9, 2009 | Nov 18, 2009 |
Also a director at
IQVIA (IQV) (no filing in the last 18 months)
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 31, 2026, Martin Marietta Materials: 66 shares awarded. 1 filing: 1
- May 29, 2026, Martin Marietta Materials: 59 shares awarded. 1 filing: 1
- May 14, 2026, Martin Marietta Materials: 313 shares awarded. 1 filing: 1
- Feb 27, 2026, Martin Marietta Materials: 47 shares awarded. 1 filing: 1
- Nov 28, 2025, Martin Marietta Materials: 51 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.